Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Appointed CFO
|
|
GILEAD SCIENCES, INC. (GILD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/05/2022 |
SC 13G
| GILEAD SCIENCES, INC. reports a 14.8% stake in ALLOVIR, INC. |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2022 |
SC 13G
| GILEAD SCIENCES INC reports a 4.3% stake in Agenus Inc. |
| 09/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/26/2020 |
SC 13G
| GILEAD SCIENCES INC reports a 13.9% stake in Jounce Therapeutics, Inc. |
| 02/10/2020 |
SC 13G
| GILEAD SCIENCES INC reports a 10% stake in Sierra Oncology, Inc. |
| 05/03/2019 |
SC 13G
| GILEAD SCIENCES INC reports a 7.7% stake in HOOKIPA PHARMA INC. |
| 02/13/2019 |
SC 13G
| Capital Research Global Investors reports a 5.6% stake in Gilead Sciences, Inc. |
| 02/13/2019 |
SC 13G
| GILEAD SCIENCES INC reports a 6.2% stake in Allogene Therapeutics, Inc. |
| 01/28/2019 |
SC 13G
| GILEAD SCIENCES INC reports a 9.3% stake in Agenus Inc. |
| 02/13/2012 |
SC 13G
| GILEAD SCIENCES INC reports a 5.5% stake in Gilead Sciences, Inc. |
| 02/14/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2007 |
SC 13G
| FMR CORP reports a 8.5% stake in Gilead Sciences Incorporated |
| 01/25/2007 |
SC 13G
| GILEAD SCIENCES INC reports a 7.2% stake in ] Achillion Pharmaceuticals Inc. |
| 01/23/2007 |
SC 13G
| BARCLAYS GLOBAL INVESTORS NA reports a 6.7% stake in GILEAD SCIENCES INC |
| 02/14/2006 |
SC 13G
| AXA FINANCIAL INC reports a 5.4% stake in GILEAD SCIENCES INC |
| 01/26/2006 |
SC 13G
| BARCLAYS GLOBAL INVESTORS NA reports a 8.6% stake in GILEAD SCIENCES INC |
| 02/14/2005 |
SC 13G
| WELLINGTON MANAGEMENT CO LLP reports a 5% stake in Gilead Sciences, Inc. |
| 02/12/2002 |
SC 13G
| PRICE T ROWE ASSOCIATES INC reports a 5.3% stake in GILEAD SCIENCES, INC. |
| 01/29/2002 |
SC 13G
| MORGAN STANLEY reports a 6.4% stake in GILEAD SCIENCES INC |
| 11/13/2001 |
SC 13G
| FMR CORP reports a 12.2% stake in Gilead Sciences Incorporated |
| 02/14/2000 |
SC 13G
| WARBURG PINCUS INVESTORS LP reports a 0% stake in Gilead Sciences, Inc. |
| 02/11/2000 |
SC 13G
| CAPITAL RESEARCH & MANAGEMENT CO reports a 4.3% stake in Gilead Sciences, Inc. |
| 02/11/2000 |
SC 13G
| CAPITAL GROUP INTERNATIONAL INC reports a 1.8% stake in Gilead Sciences, Inc. |
| 10/12/1999 |
SC 13G
| FMR CORP reports a 12.2% stake in Gilead Sciences Incorporated |
|
|